Practical Implications for the Use of Targeted Treatment in Atopic Diseases - A Q&A With Neal Jain, MD
The Clinical Relevance of IL-4/IL-13 Inhibition in Atopic Disease - A Q&A With Aiden A. Long, MD
The Significance of the Type 2 Inflammatory Spectrum - A Q&A With Mark Boguniewicz, MD
The Emerging Role of the Type 2 Inflammatory Cascade in Atopic Diseases
Evolving Treatment Strategies in Type 2 Inflammatory Disease